First Time Loading...

Lantheus Holdings Inc
NASDAQ:LNTH

Watchlist Manager
Lantheus Holdings Inc Logo
Lantheus Holdings Inc
NASDAQ:LNTH
Watchlist
Price: 63.81 USD 2.37% Market Closed
Updated: Apr 20, 2024

Intrinsic Value

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. [ Read More ]

The intrinsic value of one LNTH stock under the Base Case scenario is 134.91 USD. Compared to the current market price of 63.81 USD, Lantheus Holdings Inc is Undervalued by 53%.

Key Points:
LNTH Intrinsic Value
Base Case
134.91 USD
Undervaluation 53%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Lantheus Holdings Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling LNTH stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Lantheus Holdings Inc

Provide an overview of the primary business activities
of Lantheus Holdings Inc.

What unique competitive advantages
does Lantheus Holdings Inc hold over its rivals?

What risks and challenges
does Lantheus Holdings Inc face in the near future?

Has there been any significant insider trading activity
in Lantheus Holdings Inc recently?

Summarize the latest earnings call
of Lantheus Holdings Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Lantheus Holdings Inc.

Provide P/S
for Lantheus Holdings Inc.

Provide P/E
for Lantheus Holdings Inc.

Provide P/OCF
for Lantheus Holdings Inc.

Provide P/FCFE
for Lantheus Holdings Inc.

Provide P/B
for Lantheus Holdings Inc.

Provide EV/S
for Lantheus Holdings Inc.

Provide EV/GP
for Lantheus Holdings Inc.

Provide EV/EBITDA
for Lantheus Holdings Inc.

Provide EV/EBIT
for Lantheus Holdings Inc.

Provide EV/OCF
for Lantheus Holdings Inc.

Provide EV/FCFF
for Lantheus Holdings Inc.

Provide EV/IC
for Lantheus Holdings Inc.

Show me price targets
for Lantheus Holdings Inc made by professional analysts.

What are the Revenue projections
for Lantheus Holdings Inc?

How accurate were the past Revenue estimates
for Lantheus Holdings Inc?

What are the Net Income projections
for Lantheus Holdings Inc?

How accurate were the past Net Income estimates
for Lantheus Holdings Inc?

What are the EPS projections
for Lantheus Holdings Inc?

How accurate were the past EPS estimates
for Lantheus Holdings Inc?

What are the EBIT projections
for Lantheus Holdings Inc?

How accurate were the past EBIT estimates
for Lantheus Holdings Inc?

Compare the revenue forecasts
for Lantheus Holdings Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Lantheus Holdings Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Lantheus Holdings Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Lantheus Holdings Inc compared to its peers.

Compare the P/E ratios
of Lantheus Holdings Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Lantheus Holdings Inc with its peers.

Analyze the financial leverage
of Lantheus Holdings Inc compared to its main competitors.

Show all profitability ratios
for Lantheus Holdings Inc.

Provide ROE
for Lantheus Holdings Inc.

Provide ROA
for Lantheus Holdings Inc.

Provide ROIC
for Lantheus Holdings Inc.

Provide ROCE
for Lantheus Holdings Inc.

Provide Gross Margin
for Lantheus Holdings Inc.

Provide Operating Margin
for Lantheus Holdings Inc.

Provide Net Margin
for Lantheus Holdings Inc.

Provide FCF Margin
for Lantheus Holdings Inc.

Show all solvency ratios
for Lantheus Holdings Inc.

Provide D/E Ratio
for Lantheus Holdings Inc.

Provide D/A Ratio
for Lantheus Holdings Inc.

Provide Interest Coverage Ratio
for Lantheus Holdings Inc.

Provide Altman Z-Score Ratio
for Lantheus Holdings Inc.

Provide Quick Ratio
for Lantheus Holdings Inc.

Provide Current Ratio
for Lantheus Holdings Inc.

Provide Cash Ratio
for Lantheus Holdings Inc.

What is the historical Revenue growth
over the last 5 years for Lantheus Holdings Inc?

What is the historical Net Income growth
over the last 5 years for Lantheus Holdings Inc?

What is the current Free Cash Flow
of Lantheus Holdings Inc?

Financials

Balance Sheet Decomposition
Lantheus Holdings Inc

Current Assets 1.1B
Cash & Short-Term Investments 713.7m
Receivables 284.3m
Other Current Assets 87.9m
Non-Current Assets 565.3m
PP&E 192m
Intangibles 213.2m
Other Non-Current Assets 160.1m
Current Liabilities 187.4m
Accounts Payable 41.2m
Accrued Liabilities 132.1m
Other Current Liabilities 14.1m
Non-Current Liabilities 647.9m
Long-Term Debt 561.7m
Other Non-Current Liabilities 86.2m
Efficiency

Earnings Waterfall
Lantheus Holdings Inc

Revenue
1.3B USD
Cost of Revenue
-586.9m USD
Gross Profit
709.5m USD
Operating Expenses
-335.4m USD
Operating Income
374.1m USD
Other Expenses
-47.5m USD
Net Income
326.7m USD

Free Cash Flow Analysis
Lantheus Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

LNTH Profitability Score
Profitability Due Diligence

Lantheus Holdings Inc's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional ROE
Positive Free Cash Flow
66/100
Profitability
Score

Lantheus Holdings Inc's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

LNTH Solvency Score
Solvency Due Diligence

Lantheus Holdings Inc's solvency score is 84/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
84/100
Solvency
Score

Lantheus Holdings Inc's solvency score is 84/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LNTH Price Targets Summary
Lantheus Holdings Inc

Wall Street analysts forecast LNTH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LNTH is 99.04 USD with a low forecast of 82.82 USD and a high forecast of 134.4 USD.

Lowest
Price Target
82.82 USD
30% Upside
Average
Price Target
99.04 USD
55% Upside
Highest
Price Target
134.4 USD
111% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

LNTH Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

LNTH Price
Lantheus Holdings Inc

1M 1M
+8%
6M 6M
-8%
1Y 1Y
-29%
3Y 3Y
+202%
5Y 5Y
+165%
10Y 10Y
+964%
Annual Price Range
63.81
52w Low
51.07
52w High
99.65
Price Metrics
Average Annual Return 34.22%
Standard Deviation of Annual Returns 69.44%
Max Drawdown -69%
Shares Statistics
Market Capitalization 4.4B USD
Shares Outstanding 68 551 400
Percentage of Shares Shorted 9.13%

LNTH Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Lantheus Holdings Inc Logo
Lantheus Holdings Inc

Country

United States of America

Industry

Health Care

Market Cap

4.4B USD

Dividend Yield

0%

Description

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The company is headquartered in North Billerica, Massachusetts and currently employs 612 full-time employees. The company went IPO on 2015-06-25. The firm classify its commercial products in three categories: precision diagnostics, radiopharmaceutical oncology, and strategic partnerships and other revenue. Its products in its precision diagnostics category includes DEFINITY, TechneLite, NEUROLITE, Xenon-133, Cardiolite, Gallium-67 and Thallium-201. Its products in its radiopharmaceutical oncology category includes PYLARIFY and AZEDRA. Its products in its strategic partnerships and other revenue product category includes RELISTOR, Automated Bone Scan Index (aBSI) and PYLARIFY AI. In addition to its commercial products and strategic partnerships with third parties, it also has ongoing clinical development programs, such as 1095 and LMI 1195. Its products are sold in both the United States and internationally.

Contact

MASSACHUSETTS
North Billerica
331 Treble Cove Rd
+19786718001.0
http://www.lantheus.com/

IPO

2015-06-25

Employees

612

Officers

CEO & Director
Mr. Brian A. Markison
President
Mr. Paul M. Blanchfield
CFO & Treasurer
Mr. Robert J. Marshall Jr., CFA
Chief Administrative Officer, General Counsel & Corporate Secretary
Mr. Daniel M. Niedzwiecki
Chief Medical Officer
Dr. Jean-Claude Provost M.D.
Chief Accounting Officer
Ms. Andrea Sabens
Show More
Senior Vice President of Manufacturing & Technical Operations
Ms. Dorothy Barr
Senior Director of Investor Relations
Mr. Mark Richard Kinarney
VP of Corporate Communications & Chief of Staff
Ms. Linda S. Lennox
Senior Vice President of Quality
Ms. Carol Walker
Show Less

See Also

Discover More
What is the Intrinsic Value of one LNTH stock?

The intrinsic value of one LNTH stock under the Base Case scenario is 134.91 USD.

Is LNTH stock undervalued or overvalued?

Compared to the current market price of 63.81 USD, Lantheus Holdings Inc is Undervalued by 53%.